Published in

Elsevier, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis, (221), p. 157-163, 2023

DOI: 10.1016/j.thromres.2022.10.021

Links

Tools

Export citation

Search in Google Scholar

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

Journal article published in 2022 by Davide Voci, Andrea Götschi, Ulrike Held ORCID, Roland Bingisser, Giuseppe Colucci ORCID, Daniel Duerschmied, Riccardo M. Fumagalli, Bernhard Gerber ORCID, Barbara Hasse, Dagmar I. Keller, Stavros V. Konstantinides, François Mach, Silvana K. Rampini, Marc Righini ORCID, Helia Robert-Ebadi and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO